Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Artelo Biosciences, Inc. (ARTL) had Return on Tangible Equity of 388.98% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-12.88M |
|
-- |
|
-- |
|
$11.40M |
|
$-11.40M |
|
$-1.48M |
|
$-12.88M |
|
$-12.90M |
|
$-12.88M |
|
$-12.88M |
|
$-12.88M |
|
$-12.90M |
|
$-11.40M |
|
$-11.20M |
|
1.03M |
|
1.03M |
|
$-12.52 |
|
$-12.52 |
|
| Balance Sheet Financials | |
$0.69M |
|
-- |
|
$2.11M |
|
$2.80M |
|
$4.04M |
|
-- |
|
$0.03M |
|
$4.07M |
|
$-1.27M |
|
$-3.31M |
|
$-1.27M |
|
2.02M |
|
| Cash Flow Statement Financials | |
$-8.52M |
|
$-0.06M |
|
$6.87M |
|
$2.34M |
|
$0.60M |
|
$-1.74M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
1012.50% |
|
|
Return on Tangible Equity |
388.98% |
-459.80% |
|
1012.50% |
|
$-0.63 |
|
$-8.28 |
|
$-8.28 |
|